Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation

Oncogene volume 24, pages 889–901 (2005)Cite this article

Abstract

Deregulated c-myc gene expression is associated with many human and animal cancers. Myc overexpression promotes the growth of blood and lymphatic vessels, which is due in part to induction of growth factors including vascular endothelial growth factor (VEGF). We determined that the P493-6 human B-cell line increases VEGF production 10-fold upon Myc overexpression. Myc overexpression in avian B cells similarly resulted in high level VEGF production. Real-time RT–PCR analyses showed that Myc did not alter the VEGF mRNA content of these cell lines, indicating that a post-transcriptional mechanism regulates VEGF production. VEGF mRNA translation was examined by RT–PCR analysis of monosome and polysome sucrose gradient fractions from Myc-on and Myc-off P493-6 cells. Myc increased VEGF mRNA translation initiation, as VEGF mRNA loading onto polysomes increased 14-fold in Myc-on cells, and the number of ribosomes loaded per VEGF mRNA increased threefold. This translational regulation is specific to VEGF mRNA, as total polysomes show the same sucrose gradient profile in Myc-on and Myc-off cells, with no change in the percent ribosomes in polysomes, or in the number of ribosomes per polysomal mRNA. Myc stimulates VEGF production by a rapamycin- and LY294002-sensitive pathway, which does not involve alteration of eIF4E activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 7
Figure 3
Figure 4
Figure 5
Figure 6
Figure 8

Similar content being viewed by others

References

  • Akiri G, Nahari D, Finkelstein Y, Le SY, Elroy-Stein O and Levi BZ . ( 1998 ). Oncogene, 17, 227 – 236 .

  • Arsham AM, Howell JJ and Simon MC . ( 2003 ). J. Biol. Chem., 278, 29655 – 29660 .

  • Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H and Dang CV . ( 2000 ). Cancer Res., 60, 143 – 149 .

  • Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN and Cleveland JL . ( 2002 ). Genes Dev., 16, 2530 – 2543 .

  • Bellamy WT, Richter L, Frutiger Y and Grogan TM . ( 1999 ). Cancer Res., 59, 728 – 733 .

  • Bowers WJ, Baglia LA and Ruddell A . ( 1996 ). J. Virol., 70, 3051 – 3059 .

  • Brandvold KA, Ewert DL, Kent SC, Neiman P and Ruddell A . ( 2001 ). Oncogene, 20, 3226 – 3234 .

  • Brandvold KA, Neiman P and Ruddell A . ( 2000 ). Oncogene, 19, 2780 – 2785 .

  • Christinger HW, Muller YA, Berleau LT, Keyt BA, Cunningham BC, Ferrara N and de Vos AM . ( 1996 ). Proteins, 26, 353 – 357 .

  • Chung J, Bachelder RE, Lipscomb EA, Shaw LM and Mercurio AM . ( 2002 ). J. Cell Biol., 158, 165 – 174 .

  • Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN and Golub TR . ( 2000 ). Proc. Natl. Acad. Sci. USA, 97, 3260 – 3265 .

  • Davies E and Abe S . ( 1995 ). Methods Cell. Biol., 50, 209 – 222 .

  • De Benedetti A and Harris AL . ( 1999 ). Int. J. Biochem. Cell Biol., 31, 59 – 72 .

  • Enrietto PJ, Payne LN and Hayman MJ . ( 1983 ). Cell, 35, 369 – 379 .

  • Flamme I, von Reutern M, Drexler HC, Syed-Ali S and Risau W . ( 1995 ). Dev. Biol., 171, 399 – 414 .

  • Gingras AC, Raught B and Sonenberg N . ( 2004 ). Curr. Top Microbiol. Immunol., 279, 169 – 197 .

  • Grandori C, Cowley SM, James LP and Eisenman RN . ( 2000 ). Annu. Rev. Cell. Dev. Biol., 16, 653 – 699 .

  • Hellen CU and Sarnow P . ( 2001 ). Genes Dev., 15, 1593 – 1612 .

  • Huez I, Creancier L, Audigier S, Gensac MC, Prats AC and Prats H . ( 1998 ). Mol. Cell. Biol., 18, 6178 – 6190 .

  • Humphries EH and Baba TW . ( 1984 ). Curr. Top. Microbiol. Immunol., 113, 47 – 55 .

  • Iritani BM and Eisenman RN . ( 1999 ). Proc. Natl. Acad. Sci. USA, 96, 13180 – 13185 .

  • Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB and Thomas G . ( 1997 ). EMBO J., 16, 3693 – 3704 .

  • Jones RM, Branda J, Johnston KA, Polymenis M, Gadd M, Rustgi A, Callanan L and Schmidt EV . ( 1996 ). Mol. Cell. Biol., 16, 4754 – 4764 .

  • Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, Delecluse HJ, Rottenberger C, Bornkamm GW and Hammerschmidt W . ( 1995 ). EMBO J., 14, 88 – 96 .

  • Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS and Alexander JS . ( 1996 ). Int. J. Cancer, 65, 785 – 790 .

  • Lawrence Jr JC and Abraham RT . ( 1997 ). Trends Biochem. Sci., 22, 345 – 349 .

  • Levy AP, Levy NS and Goldberg MA . ( 1996 ). J. Biol. Chem., 271, 2746 – 2753 .

  • Lewis RB, McClure J, Rup B, Niesel DW, Garry RF, Hoelzer JD, Nazerian K and Bose Jr HR . ( 1981 ). Cell, 25, 421 – 431 .

  • Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM and Dvorak HF . ( 2002 ). J. Exp. Med., 196, 1497 – 1506 .

  • Neiman PE, Ruddell A, Jasoni C, Loring G, Thomas SJ, Brandvold KA, Lee R, Burnside J and Delrow J . ( 2001 ). Proc. Natl. Acad. Sci. USA, 98, 6378 – 6383 .

  • Nesbit CE, Tersak JM and Prochownik EV . ( 1999 ). Oncogene, 18, 3004 – 3016 .

  • Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege MS, Brielmeier M, Ellwart J, Kohlhuber F, Bornkamm GW, Polack A and Eick D . ( 2000 ). Int. J. Cancer, 87, 787 – 793 .

  • Pelengaris S, Littlewood T, Khan M, Elia G and Evan G . ( 1999 ). Mol. Cell., 3, 565 – 577 .

  • Rajasekhar VK, Viale A, Socci ND, Wiedmann M, Hu X and Holland EC . ( 2003 ). Mol. Cell, 12, 889 – 901 .

  • Raught B, Gingras AC, Gygi SP, Imataka H, Morino S, Gradi A, Aebersold R and Sonenberg N . ( 2000 ). EMBO J., 19, 434 – 444 .

  • Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ and Schmidt EV . ( 1993 ). Proc. Natl. Acad. Sci. USA, 90, 6175 – 6178 .

  • Ruddell A, Mezquita P, Brandvold KA, Farr A and Iritani BM . ( 2003 ). Am. J. Pathol., 163, 2233 – 2245 .

  • Satake S, Kuzuya M, Miura H, Asai T, Ramos MA, Muraguchi M, Ohmoto Y and Iguchi A . ( 1998 ). Biol. Cell, 90, 161 – 168 .

  • Scheper GC and Proud CG . ( 2002 ). Eur. J. Biochem., 269, 5350 – 5359 .

  • Schmidt EV . ( 1999 ). Oncogene, 18, 2988 – 2996 .

  • Schuhmacher M, Staege MS, Pajic A, Polack A, Weidle UH, Bornkamm GW, Eick D and Kohlhuber F . ( 1999 ). Curr. Biol., 9, 1255 – 1258 .

  • Shiio Y, Donohoe S, Yi EC, Goodlett DR, Aebersold R and Eisenman RN . ( 2002 ). EMBO J., 21, 5088 – 5096 .

  • Shweiki D, Itin A, Soffer D and Keshet E . ( 1992 ). Nature, 359, 843 – 845 .

  • Smith DR, Vennstrom B, Hayman MJ and Enrietto PJ . ( 1985 ). J. Virol., 56, 969 – 976 .

  • Stein I, Neeman M, Shweiki D, Itin A and Keshet E . ( 1995 ). Mol. Cell. Biol., 15, 5363 – 5368 .

  • Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, Dvorak AM and Dvorak HF . ( 2001 ). Am. J. Pathol., 158, 1145 – 1160 .

  • Tuxworth Jr WJ, Saghir AN, Spruill LS, Menick DR and McDermott PJ . ( 2004 ). Biochem. J., 378, 73 – 82 .

  • Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F and Dammacco F . ( 1994 ). Br. J. Haematol., 87, 503 – 508 .

  • Vacca A, Ribatti D, Ruco L, Giacchetta F, Nico B, Quondamatteo F, Ria R, Iurlaro M and Dammacco F . ( 1999 ). Br. J. Cancer, 79, 965 – 970 .

  • Vivanco I and Sawyers CL . ( 2002 ). Nat. Rev. Cancer, 2, 489 – 501 .

  • Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR and Cooper JA . ( 1999 ). Mol. Cell. Biol., 19, 1871 – 1880 .

  • Willis AE, Paulin FE, West MJ and Whitney RL . ( 1997 ). Curr. Top. Microbiol. Immunol., 224, 269 – 276 .

Download references

Acknowledgements

We thank Adam Geballe, Robert Eisenman, Carla Grandori, Stephanie Child, and Paul Neiman for their valuable expertise and advice, and Dirk Eick for providing P493-6 cells. This work was supported by a grant from the Elsa U Pardee Foundation and by Public Health Service Grant CA68328 from the National Cancer Institute.

Author information

Authors and Affiliations

  1. Division of Basic Science, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Pau Mezquita, Sean S Parghi, Kimberly A Brandvold & Alanna Ruddell

Authors
  1. Pau Mezquita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sean S Parghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kimberly A Brandvold
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alanna Ruddell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alanna Ruddell.

Additional information

Supplementary information accompanies the paper on Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mezquita, P., Parghi, S., Brandvold, K. et al. Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation. Oncogene 24, 889–901 (2005). https://doi.org/10.1038/sj.onc.1208251

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208251

Keywords

This article is cited by

Search

Advanced search

Quick links